188
Views
1
CrossRef citations to date
0
Altmetric
Review

Toxic Effect of Mycotoxins on Cardiovascular System: A Topic Worthy of Further Study

, , &

References

  • Helis, E.; Augustincic, L.; Steiner, S.; Chen, L.; Turton, P.; Fodor, J. G. Time Trends in Cardiovascular and All-cause Mortality in the “Old” and “New” European Union Countries. Eur. J. Cardiovasc. Prev. Rehabil. 2011 Jun, 18(3), 347–359. DOI:10.1177/1741826710389361.
  • Wilkins, J. T.; Ning, H.; Berry, J.; Zhao, L.; Dyer, A. R.; Lloyd-Jones, D. M. Lifetime Risk and Years Lived Free of Total Cardiovascular Disease. JAMA. Nov 7, 2012, 308(17), 1795–1801. DOI:10.1001/jama.2012.14312.
  • Li, Q.; Liu, M.; Hou, J.; Jiang, C.; Li, S.; Wang, T. The Prevalence of Keshan Disease in China. Int. J. Cardiol. Sep 30, 2013, 168(2), 1121–1126.
  • Gill, G. V.; Henry, L.; Reid, H. A. Chronic Cardiac Beriberi in a Former Prisoner of the Japanese. Br. J. Nutr. Nov 1980, 44(3), 273–274. doi:10.1079/BJN19800041.
  • Liu, X.; Yang, G.; Wang, L. X.; Wei, J.; Tan, W. H.; Zhu, Y. H. Progressive Risks of Latent Keshan Disease: A Long Term Follow-up Study. Sichuan Xue Xue Bao Yi Xue Ban 2016 May, 47(3), 398–401, 424.
  • Yang, G.; Zhu, Y.; Dong, X.; Duan, Z.; Niu, X.; Wei, J. TLR2-ICAM1-Gadd45alpha Axis Mediates the Epigenetic Effect of Selenium on DNA Methylation and Gene Expression in Keshan Disease. Biol. Trace Elem. Res. Jun 2014, 159(1–3), 69–80. doi:10.1007/s12011-014-9985-8.
  • Yang, J.; Yang, Q. Study on the Cause of Keshan Disease. Chin. J. Endemiol. 2000, 5, 32–37.
  • Yang, J.;. Study on the Etiology and Epidemic Mechanism of Keshan Disease; 1st.; Heilongjiang Science and Technology Press: Harbin, China, 2014; pp 68–76.
  • Pei, J.; Fu, W.; Yang, L.; Zhang, Z.; Liu, Y. Oxidative Stress Is Involved in the Pathogenesis of Keshan Disease (An Endemic Dilated Cardiomyopathy) in China. Oxid. Med. Cell. Longev. 2013, 2013, 474203. DOI: 10.1155/2013/474203.
  • Nishie, K.; Cole, R. J.; Dorner, J. W. Toxicity of Citreoviridin. Res Commun Chem Pathol. Pharmacol. 1988 Jan, 59(1), 31–52.
  • Sun, Y. X.; Zhu, Y. H.; Zhu, J. H.; Niu, X. L.; Yan, C.; Yang, G.; et al. Two-dimensional Gel Electrophoresis Map of Serum Proteins in Patients with Chronic Keshan Disease. Sichuan Xue Xue Bao Yi Xue Ban. 2013 May, 44(3), 388–392.
  • Ohta, Y.; Nakano, A.; Matsumoto, M. Concentration of Trace Elements in Hair from Children Living in a Keshan Disease District in China. Nihon Eiseigaku Zasshi. 1992 Oct, 47(4), 811–817. DOI:10.1265/jjh.47.811.
  • Liu, Y.; Chiba, M.; Inaba, Y.; Kondo, M. Keshan Disease--a Review from the Aspect of History and Etiology. Nihon Eiseigaku Zasshi. 2002 Jan, 56(4), 641–648. DOI:10.1265/jjh.56.641.
  • Sun, S.;. Chronic Exposure to Cereal Mycotoxin Likely Citreoviridin May Be a Trigger for Keshan Disease Mainly through Oxidative Stress Mechanism. Med. Hypotheses. May 2010, 74(5), 841–842. doi:10.1016/j.mehy.2009.11.043.
  • Megaw, J. W. D.; Bhattacharjee, S. P. An Outbreak of the Epidemic Dropsy Form of Beriberi in Calcutta. Ind. Med. Gaz. 1924 Apr, 59(4), 169–173.
  • Pitt, J. I.; Miller, J. D.; Concise, A. History of Mycotoxin Research. J. Agric. Food Chem. Aug 23, 2017, 65(33), 7021–7033. DOI:10.1021/acs.jafc.6b04494.
  • Yamashita, N.; Aikawa, T. Dutch Research on Beriberi: I. Christiaan Eijkman’s Research and Evaluation of Kanehiro Takaki’s Diet Reforms of the Japanese Navy. Nihon Ishigaku Zasshi. 2017 Mar, 63(1), 3–21.
  • Lima, H. C.; Porto, E. A.; Marins, J. R.; Alves, R. M.; Machado, R. R.; Braga, K. N.; de Paiva, F. B.; Carmo, G. M. I.; Faria Silva e Santelli, A. C.; Sobel, J.; et al. Outbreak of Beriberi in the State of Maranhao, Brazil: Revisiting the Mycotoxin Aetiologic Hypothesis. Trop. Doct. 2010 Apr, 40(2), 95–97. DOI:10.1258/td.2009.090439.
  • Sugiyama, Y.; Seita, A. Kanehiro Takaki and the Control of Beriberi in the Japanese Navy. J. R. Soc. Med. Aug 2013, 106(8), 332–334. doi:10.1177/0141076813497889.
  • Yang, F. Y.; Lin, Z. H.; Li, S. G.; Guo, B. Q.; Yin, Y. S. Keshan Disease--an Endemic Mitochondrial Cardiomyopathy in China. J. Trace. Elem. Electrolytes Health Dis. 1988 Sep, 2(3), 157–163.
  • Linnett, P. E.; Mitchell, A. D.; Osselton, M. D.; Mulheirn, L. J.; Beechey, R. B. Citreoviridin, a Specific Inhibitor of the Mitochondiral Adenosine Triphosphatase. Biochem. J. Mar 15, 1978, 170(3), 503–510. DOI:10.1042/bj1700503.
  • Hou, H.; Zhou, R.; Li, A.; Li, C.; Li, Q.; Liu, J.; Jiang, B.; et al. Citreoviridin Inhibits Cell Proliferation and Enhances Apoptosis of Human Umbilical Vein Endothelial Cells. Env. Toxicol. Pharmacol. 2014 Mar, 37(2), 828–836. DOI:10.1016/j.etap.2014.02.016.
  • Feng, C.; Li, D.; Chen, M.; Jiang, L.; Liu, X.; Li, Q.; Geng, C.; Sun, X.; Yang, G.; Zhang, L.; et al. Citreoviridin Induces Myocardial Apoptosis through PPAR-gamma-mTORC2-mediated Autophagic Pathway and the Protective Effect of Thiamine and Selenium. Chem. Biol. Interact. 2019 Sep 25, 311, 108795. DOI: 10.1016/j.cbi.2019.108795.
  • Hensrud, D. D.; Heimburger, D. C.; Chen, J.; Parpia, B. Antioxidant Status, Erythrocyte Fatty Acids, and Mortality from Cardiovascular Disease and Keshan Disease in China. Eur. J. Clin. Nutr. 1994 Jul, 48(7), 455–464.
  • Hou, H. F.; Yuan, N.; Guo, Q.; Sun, T.; Li, C.; Liu, J. B.; et al. Citreoviridin Enhances Atherogenesis in Hypercholesterolemic ApoE-Deficient Mice via Upregulating Inflammation and Endothelial Dysfunction. PLoS One. 2015, 10(5), e0125956.
  • Almeida, M. I.; Almeida, N. G.; Carvalho, K. L.; Goncalves, G. A.; Silva, C. N.; Santos, E. A.; et al. Co-occurrence of Aflatoxins B(1), B(2), G(1) and G(2), Ochratoxin A, Zearalenone, Deoxynivalenol, and Citreoviridin in Rice in Brazil. Food Addit. Contam. Part. Chem. Anal. Control Expo. Risk Assess. 2012, 29(4), 694–703.
  • Van Egmond, H. P.; Paulsch, W. E.; Sizoo, E. A. Comparison of Six Methods of Analysis for the Determination of Aflatoxin B1 in Feeding Stuffs Containing Citrus Pulp. Food Addit. Contam. Jul 1988, 5(3), 321–332. doi:10.1080/02652038809373711.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.